GHRP-2 (10mg)

What is GHRP-2 (10mg)?

GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide classified as a growth hormone secretagogue. Peptides in this category have been widely studied in experimental research for their ability to influence biological pathways associated with growth hormone signaling. GHRP-2 contains a defined sequence of six amino acids, designed to mimic certain peptide signals that participate in endocrine communication within laboratory models. In laboratory studies, GHRP-2 has been investigated for its potential involvement in metabolic signaling, endocrine pathways, and cellular processes related to growth-factor regulation.

What are the key features of GHRP-2 (10mg)?

GHRP-2 (10mg) is commonly supplied as a lyophilized peptide powder in a sterile research vial. The 10 mg vial format is often selected by laboratories conducting extended studies or experiments that require multiple preparations from the same batch of peptide.

Key Features

• Peptide classification: Synthetic growth hormone-releasing peptide
• CAS Number: 158861-67-7
• Sequence: H-D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2
• Chemical Formula: C₄₅H₅₅N₉O₆
• Molecular Weight: 817.97 g/mol
• Purity: Typically ≥98%, confirmed through HPLC and MS analysis
• Format: Lyophilized peptide supplied in a sterile research vial
• Research focus: Investigated in endocrine signaling and metabolic pathway studies
• For laboratory research use only

How is GHRP-2 (10mg) synthesized?

GHRP-2 is produced using solid-phase peptide synthesis (SPPS), a widely used method for manufacturing short peptides with precise amino acid sequences. During synthesis, individual amino acids are sequentially added to a peptide chain anchored to a solid resin. This step-by-step process allows researchers to control the exact structure of the final peptide. After assembly of the six-amino-acid chain, the peptide is cleaved from the resin, purified, and lyophilized into a stable powder. Analytical verification is typically performed using high-performance liquid chromatography (HPLC) to confirm purity, and mass spectrometry (MS) to verify the peptide’s molecular weight and structural identity. These quality control procedures help ensure consistency for laboratory research applications.

What is GHRP-2 (10mg) being studied for? What are its possible benefits?

GHRP-2 has been studied for its potential role in growth hormone signaling and metabolic regulation. Researchers are investigating its effects on growth hormone release and on the subsequent modulation of metabolic processes in experimental models. Research areas include:

• Growth hormone secretion dynamics
• Endocrine signaling regulation
• Protein metabolism and cell growth regulation
• Cellular repair and regeneration mechanisms

These findings are derived from preclinical research and experimental studies. They do not represent established clinical benefits or therapeutic claims.

How does GHRP-2 (10mg) work in research studies?

In experimental settings, GHRP-2 is studied for its ability to influence growth hormone signaling pathways. GHRP-2 is studied as a selective agonist of the growth hormone secretagogue receptor (GHS-R1a), also known as the ghrelin receptor, in experimental models. Laboratory observations indicate that these signaling interactions may influence processes such as protein synthesis, cellular metabolism, and growth-related cellular responses. Scientists continue to investigate how GHRP-2 may interact with intracellular signaling pathways that regulate metabolic and endocrine activity. Much of the current understanding comes from cell culture experiments and animal model studies.

What dosing information exists for GHRP-2 (10mg)?

Scientific literature on GHRP-2 primarily reports dosing parameters used in preclinical experiments. In some animal studies, the peptide has been evaluated at doses ranging from approximately 1–10 µg/kg to assess its influence on growth hormone signaling and related biological pathways. In in-vitro laboratory studies, GHRP-2 has been tested at nanomolar to micromolar concentrations depending on the cell type and experimental design. These concentrations reflect experimental conditions used for research purposes. Currently, no established dosing guidelines exist for human or veterinary use, and reported values should only be interpreted within the context of laboratory research.

How should GHRP-2 (10mg) be stored and handled?

Store GHRP-2 (10mg) at –20 °C in a sealed, airtight container, protected from light and moisture. If reconstituted for experimental use, short-term storage at 2–8 °C is recommended. Avoid repeated freeze–thaw cycles, as these may reduce peptide stability. Refer to the supplier's COA for lot-specific stability data. Proper laboratory handling procedures, including sterile technique and accurate volumetric measurement, are recommended to ensure experimental consistency.

Where can I read more research about GHRP-2 (10mg)?

1. Kageyama K, Kushibiki M, Hanada K, Sakihara S, Yasujima M, Suda T. Growth hormone-releasing peptide-2 stimulates secretion and synthesis of adrenocorticotropic hormone in mouse pituitary. Regul Pept. 2009;158(1-3):116-120. doi:10.1016/j.regpep.2009.07.018
2. Hu R, Wang Z, Peng Q, et al. Effects of GHRP-2 and Cysteamine Administration on Growth Performance, Somatotropic Axis Hormone and Muscle Protein Deposition in Yaks (Bos grunniens) with Growth Retardation. PLoS One. 2016;11(2):e0149461. Published 2016 Feb 19. doi:10.1371/journal.pone.0149461
3. Laferrère B, Hart AB, Bowers CY. Obese subjects respond to the stimulatory effect of the ghrelin agonist growth hormone-releasing peptide-2 on food intake. Obesity (Silver Spring). 2006;14(6):1056-1063. doi:10.1038/oby.2006.121
4. Arvat E, Maccario M, Di Vito L, et al. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab. 2001;86(3):1169-1174. doi:10.1210/jcem.86.3.7314
5. Petersenn S, Rasch AC, Penshorn M, Beil FU, Schulte HM. Genomic structure and transcriptional regulation of the human growth hormone secretagogue receptor. Endocrinology. 2001;142(6):2649-2659. doi:10.1210/endo.142.6.8184

Compliance Statement

This product is intended for laboratory research use only and is not approved for human or veterinary use.